<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36445001</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Prevalence and determinants of language impairment in non-demented amyotrophic lateral sclerosis patients.</ArticleTitle><Pagination><StartPage>606</StartPage><EndPage>611</EndPage><MedlinePgn>606-611</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.15652</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">This study aimed at estimating the prevalence of language impairment (LI) in a large, clinic-based cohort of non-demented amyotrophic lateral sclerosis (ALS) patients and assessing its underpinnings at motor and non-motor levels.</AbstractText><AbstractText Label="METHODS">Non-demented ALS patients (N&#xa0;=&#xa0;348) underwent the Edinburgh Cognitive and Behavioural ALS Screen (ECAS), as well as an assessment of behavioural/psychiatric and motor-functional features. The prevalence of LI was estimated based on the proportion of patients showing a performance below the age- and education-adjusted cut-off on the ECAS-Language. Multiple regression models were run to assess the determinants of language functioning and impairment.</AbstractText><AbstractText Label="RESULTS">The prevalence of LI was 22.7%. 46.6% of the variance of ECAS-Language scores remained unexplained, with only the ECAS-Executive positively predicting them (p&#x2009;&lt;&#x2009;0.001; &#x3b7;<sup>2</sup> &#xa0;=&#xa0;0.07). Similarly, only a lower score on the ECAS-Executive predicted a higher probability of a below cut-off ECAS-Language performance (p&#x2009;&lt;&#x2009;0.001). Spelling and Naming tasks were the major drivers of ECAS-Language performance.</AbstractText><AbstractText Label="CONCLUSIONS">This study suggests that, in non-demented ALS patients, LI occurs in &#x2248;23% of cases, is significantly driven by executive dysfunction but, at the same time, partially independent of it and is not associated with other motor or non-motor features.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Solca</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aiello</LastName><ForeName>Edoardo Nicol&#xf2;</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torre</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carelli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrucci</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5109-9483</Identifier><AffiliationInfo><Affiliation>Aldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, International Medical School, University of Milan, Milano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verde</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari Center', Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ticozzi</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5963-7426</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari Center', Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, 'Dino Ferrari Center', Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monti</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation Sciences, Casa di Cura del Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poletti</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4398-2051</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007805" MajorTopicYN="Y">Language Development Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Edinburgh Cognitive and Behavioural ALS Screen</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">frontotemporal degeneration</Keyword><Keyword MajorTopicYN="N">language</Keyword><Keyword MajorTopicYN="N">primary progressive aphasia</Keyword></KeywordList><CoiStatement>V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l. and Novartis Pharma AG, receives or has received research support from the Italian Ministry of Health, AriSLA and E&#x2010;Rare Joint Transnational Call. He is on the Editorial Board of <i>Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>, <i>European Neurology</i>, <i>American Journal of Neurodegenerative Diseases</i>, <i>Frontiers in Neurology</i>. B.P. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. N. T. received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for <i>Frontiers in Aging Neuroscience</i>.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36445001</ArticleId><ArticleId IdType="pmc">PMC10108014</ArticleId><ArticleId IdType="doi">10.1111/ene.15652</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis&#x2010;frontotemporal spectrum disorder (ALS&#x2010;FTSD): revised diagnostic criteria. Amyotrophic Lateral Scler Frontotemporal Degener. 2017;18:153&#x2010;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto&#x2010;Grau M, Hardiman O, Pender N. The study of language in the amyotrophic lateral sclerosis&#x2010;frontotemporal spectrum disorder: a systematic review of findings and new perspectives. Neuropsychol Rev. 2018;28:251&#x2010;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">29705950</ArticleId></ArticleIdList></Reference><Reference><Citation>Sbrollini B, Preti AN, Zago S, Papagno C, Appollonio IM, Aiello EN. Language impairment in motor neuron disease phenotypes different from classical amyotrophic lateral sclerosis: a review. Aphasiology. 2022;36:1373&#x2010;1396.</Citation></Reference><Reference><Citation>Aiello EN, Feroldi S, Preti AN, Zago S, Appollonio IM. Dysgraphic features in motor neuron disease: a review. Aphasiology. 2022;36:1249&#x2010;1274.</Citation></Reference><Reference><Citation>Huynh W, Ahmed R, Mahoney CJ, et al. The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis. Expert Rev Neurother. 2020;20:281&#x2010;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">32031423</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Dalla Bella E, Bersano E, Lauria G. Cognitive and behavioural impairment in amyotrophic lateral sclerosis: a landmark of the disease? A mini review of longitudinal studies. Neurosci Lett. 2021;754:135898.</Citation><ArticleIdList><ArticleId IdType="pubmed">33862143</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley SC, Rush BK. Considerations for clinical neuropsychological evaluation in amyotrophic lateral sclerosis. Arch Clin Neuropsychol. 2017;32:906&#x2010;916.</Citation><ArticleIdList><ArticleId IdType="pubmed">29028904</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor LJ, Brown RG, Tsermentseli S, et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry. 2013;84:494&#x2010;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">23033353</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto&#x2010;Grau M, Donohoe B, O'Connor S, et al. Patterns of language impairment in early amyotrophic lateral sclerosis. Neurol Clin Pract. 2021;11:e634&#x2010;e644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610537</ArticleId><ArticleId IdType="pubmed">34840877</ArticleId></ArticleIdList></Reference><Reference><Citation>Shellikeri S, Karthikeyan V, Martino R, et al. The neuropathological signature of bulbar&#x2010;onset ALS: a systematic review. Neurosci Biobehav Rev. 2017;75:378&#x2010;392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5425954</ArticleId><ArticleId IdType="pubmed">28163193</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, Feroldi S, De Luca G, et al. Primary progressive aphasia and motor neuron disease: a review. Front Aging Neurosci. 2022;14:1003792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9492890</ArticleId><ArticleId IdType="pubmed">36158556</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2010;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456&#x2010;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno&#x2010;Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006&#x2010;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, et al. The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:489&#x2010;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Aiello EN, Solca F, et al. Diagnostic properties of the Italian ECAS Carer Interview (ECAS&#x2010;CI). Neurol Sci. 2022;98:1&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9925466</ArticleId><ArticleId IdType="pubmed">36417015</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561&#x2010;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">13688369</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielberger CD, Gonzalez&#x2010;Reigosa F, Martinez&#x2010;Urrutia A, Natalicio LF, Natalicio DS. The state&#x2010;trait anxiety inventory. Int J Psychol. 1971;5:145&#x2010;158.</Citation></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS&#x2010;R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas&#x2010;Garcia R, Scott KM, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847&#x2010;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:38&#x2010;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura FCSHDH, Fujimura C, Ishida S, et al. Progression rate of ALSFRS&#x2010;R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265&#x2010;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HY. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38:52&#x2010;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3591587</ArticleId><ArticleId IdType="pubmed">23495371</ArticleId></ArticleIdList></Reference><Reference><Citation>Midi H, Sarkar SK, Rana S. Collinearity diagnostics of binary logistic regression model. J Interdiscip Math. 2010;13:253&#x2010;267.</Citation></Reference><Reference><Citation>Schrempf T, Finsel J, Uttner I, Ludolph AC, Lul&#xe9; D. Neuropsychological deficits have only limited impact on psychological well&#x2010;being in amyotrophic lateral sclerosis. J Neurol. 2022;269:1369&#x2010;1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8857089</ArticleId><ArticleId IdType="pubmed">34215919</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan CT, Wuu J, Rascovsky K, et al. Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:1&#x2010;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9448823</ArticleId><ArticleId IdType="pubmed">35253557</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, Iazzolino B, Pain D, et al. The diagnostic value of the Italian version of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:527&#x2010;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">35311435</ArticleId></ArticleIdList></Reference><Reference><Citation>Astell AJ, Harley TA. Naming problems in dementia: semantic or lexical? Aphasiology. 1998;12:357&#x2010;374.</Citation></Reference><Reference><Citation>Strain E, Patterson K, Seidenberg MS. Semantic effects in single&#x2010;word naming. J Exp Psychol Learn Mem Cogn. 1995;21:1140&#x2010;1154.</Citation><ArticleIdList><ArticleId IdType="pubmed">8744959</ArticleId></ArticleIdList></Reference><Reference><Citation>Croisile B, Brabant MJ, Carmoi T, Lepage Y, Aimard G, Trillet M. Comparison between oral and written spelling in Alzheimer's disease. Brain Lang. 1996;54:361&#x2010;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">8866054</ArticleId></ArticleIdList></Reference><Reference><Citation>Catrical&#xe0; E, Gobbi E, Battista P, et al. SAND: a Screening for Aphasia in NeuroDegeneration. Development and normative data. Neurol Sci. 2017;38:1469&#x2010;1483.</Citation><ArticleIdList><ArticleId IdType="pubmed">28578483</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel N, Peterson KA, Ingram RU, et al. A &#x2018;mini linguistic state examination&#x2019; to classify primary progressive aphasia. Brain Commun. 2022;4:fcab299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8914496</ArticleId><ArticleId IdType="pubmed">35282164</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside DM, Kealey T, Semla M, et al. Verbal fluency: language or executive function measure? Appl Neuropsychol Adult. 2016;23:29&#x2010;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">26111011</ArticleId></ArticleIdList></Reference><Reference><Citation>Aita SL, Beach JD, Taylor SE, Borgogna NC, Harrell MN, Hill BD. Executive, language, or both? An examination of the construct validity of verbal fluency measures. Appl Neuropsychol Adult. 2018;26(5):441&#x2010;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">29513079</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory JM, McDade K, Bak TH, et al. Executive, language and fluency dysfunction are markers of localised TDP&#x2010;43 cerebral pathology in non&#x2010;demented ALS. J Neurol Neurosurg Psychiatry. 2020;91:149&#x2010;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6996101</ArticleId><ArticleId IdType="pubmed">31515300</ArticleId></ArticleIdList></Reference><Reference><Citation>Panopoulou N, Christidi F, Kourtesis P, et al. The association of theory of mind with language and visuospatial abilities in amyotrophic lateral sclerosis: a pilot study. Amyotroph Lateral Scler Frontotemporal Degener. 2021;23:1&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34907827</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Byrne S, et al. Cognitive changes predict functional decline in ALS: a population&#x2010;based longitudinal study. Neurology. 2013;80:1590&#x2010;1597.</Citation><ArticleIdList><ArticleId IdType="pubmed">23553481</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, et al. ALS&#x2010;specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370&#x2010;e1380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6177274</ArticleId><ArticleId IdType="pubmed">30209236</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, et al. Cognitive impairment across ALS clinical stages in a population&#x2010;based cohort. Neurology. 2019;93:e984&#x2010;e994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6745732</ArticleId><ArticleId IdType="pubmed">31409738</ArticleId></ArticleIdList></Reference><Reference><Citation>Iazzolino B, Peotta L, Zucchetti JP, et al. Differential neuropsychological profile of patients with amyotrophic lateral sclerosis with and without C9orf72 mutation. Neurology. 2021;96:e141&#x2010;e152.</Citation><ArticleIdList><ArticleId IdType="pubmed">33106391</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, Pain D, Radici A, et al. Cognition and motor phenotypes in ALS: a retrospective study. Neurol Sci. 2022;43:4599&#x2010;4604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385798</ArticleId><ArticleId IdType="pubmed">35608739</ArticleId></ArticleIdList></Reference><Reference><Citation>McHutchison CA, Leighton DJ, McIntosh A, et al. Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND. J Neurol Neurosurg Psychiatry. 2020;91:245&#x2010;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">31871139</ArticleId></ArticleIdList></Reference><Reference><Citation>Canu E, Agosta F, Battistella G, et al. Speech production differences in English and Italian speakers with nonfluent variant PPA. Neurology. 2020;94:e1062&#x2010;e1072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7238919</ArticleId><ArticleId IdType="pubmed">31924679</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, Trojano L, Trojsi F, et al. Edinburgh Cognitive and Behavioural ALS Screen (ECAS)&#x2014;Italian version: regression based norms and equivalent scores. Neurol Sci. 2017;38:1059&#x2010;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">28332040</ArticleId></ArticleIdList></Reference><Reference><Citation>Manera U, Peotta L, Iazzolino B, et al. The characteristics of cognitive impairment in ALS patients depend on the lateralization of motor damage. Brain Sci. 2020;10:650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7563934</ArticleId><ArticleId IdType="pubmed">32961718</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, Palumbo F, Iazzolino B, et al. The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in amyotrophic lateral sclerosis. Neurobiol Aging. 2021;98:205&#x2010;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">33316576</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>